Skip to content
  • RESEARCH
  • PUBLICATIONS
  • TEAM
  • LAB NEWS
  • CONTACT
  • RESEARCH
  • PUBLICATIONS
  • TEAM
  • LAB NEWS
  • CONTACT

© 2019

Development of a colon cancer GEMM-derived orthotopic transplant model for drug discovery and validation.

Martin ES, Belmont PJ, Sinnamon MJ, Richard LG, Yuan J, Coffee EM, Roper J, Lee L, Heidari P, Lunt SY, Goel G, Ji C, Xie J, Xie T, Lamb J, Weinrich S, Vanarsdale TL, Bronson RT, Xavier RJ, Vander Heiden M, Kan J, Mahmood U, Hung KE.

Development of a colon cancer GEMM-derived orthotopic transplant model for drug discovery and validation.

Clin Cancer Res. 2013 Jun 1;19(11):2929–40. PMID: 23403635, PMCID: 3951107

2013

Tags
2013

Post navigation

Previous post Priceless GEMMs: genetically engineered mouse models for colorectal cancer drug development.

Post navigation

Next post Concomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer.
Recent Posts
  • Weight Loss and/or Sulindac Mitigate Obesity-associated Transcriptome, Microbiome, and Protumor Effects in a Murine Model of Colon Cancer
  • CAUSE, EPIDEMIOLOGY, AND HISTOLOGY OF POLYPS AND PATHWAYS TO COLORECTAL CANCER
  • SPECTROSCOPIC OPTICAL COHERENCE TOMOGRAPHY FOR CLASSIFICATION OF COLORECTAL CANCER IN A MOUSE MODEL
  • METABOLISM AND COLORECTAL CANCER
  • MIRROR MIRROR ON THE WALL, WHO IS THE FITTEST OF THEM ALL: A NOVEL PREDICTION MODEL FOR POSTOPERATIVE HEPATIC DECOMPENSATION IN PATIENTS WITH CIRRHOSIS
Archives
  • April 2023
  • January 2022
  • February 2020
  • January 2020
Categories
  • Publications
Meta
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
© 2025 Roper Labs. Created for free using WordPress and Colibri